午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Organic Chemistry>Ethers and derivatives>1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
  • 1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
  • 1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
  • 1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole

1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole NEW

Price Get Latest Price
Package 1kg 25kg
Min. Order: 1kg
Supply Ability: 800kg
Update Time: 2025-04-01

Product Details

Product Name: 1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole CAS No.: 1029716-44-6
Min. Order: 1kg Purity: 0.99
Supply Ability: 800kg Release date: 2025/04/01

?Baricitinib Intermediate (CAS 1029716-44-6)?
Google Keywords: Baricitinib Intermediate, CAS 1029716-44-6, JAK Inhibitor Synthesis, Rheumatoid Arthritis API Intermediates, GMP Pharmaceutical Manufacturing


?? ?Product Overview?

?Baricitinib Intermediate? (CAS 1029716-44-6) is a high-purity chemical intermediate essential for synthesizing ?Baricitinib?, a Janus kinase (JAK) inhibitor approved for treating rheumatoid arthritis and severe inflammatory conditions. This intermediate ensures precision and scalability in API production while adhering to stringent pharmaceutical quality standards.

  1. ?Primary Function?: Acts as a critical building block in the multi-step synthesis of Baricitinib API.

  2. ?Applications?: Rheumatoid arthritis drug development, JAK inhibitor manufacturing, and large-scale API production.


? ?Key Advantages?

?? ?Ultra-High Purity? | ≥99.0% (HPLC/GC verified) | Complies with ICH Q11 guidelines for intermediates.
?? ?Scalable Synthesis? | Optimized for high-yield, cost-effective manufacturing with minimal impurities.
?? ?Regulatory Compliance? | Fully characterized by NMR, HRMS, and FTIR to support FDA/EMA submissions and GMP audits.


?? ?Applications?

  • ?API Production?: Enables efficient synthesis of Baricitinib with consistent quality.

  • ?Process Optimization?: Supports R&D in refining synthetic pathways for improved efficiency.

  • ?Quality Control?: Used in analytical method validation and batch release testing.


?? ?Quality Assurance?

  • ?Testing Methods?: HPLC, GC, NMR, HRMS, and FTIR for structural confirmation and purity analysis.

  • ?Standards?: Meets USP <1086>, EP 10.0, and ISO 9001:2015 certified manufacturing protocols.


?? ?Market Trends?

The ?global rheumatoid arthritis treatment market? is projected to exceed ?$38.5 billion by 2030? (CAGR 5.8%), driven by rising autoimmune disease prevalence and demand for targeted therapies like JAK inhibitors. Baricitinib intermediates are pivotal in accelerating generic and innovative drug development post-patent expiry.


Enhance your JAK inhibitor production with Baricitinib Intermediate – precision-engineered for quality, scalability, and regulatory excellence.


Article illustration

Article illustration

Article illustration


Company Profile Introduction

Wuhan Biocar Pharmaceutical Co., Ltd. is a high-tech and innovative enterprise specializing in the research, development, production, and sales of APIs and pharmaceutical intermediates (excluding finished drugs). Located in the heart of Optics Valley Biological City, our company leverages the cutting-edge facilities of the Wuhan University Scientific Research Laboratory and benefits from the region's favorable policies to advance the field of biomedicine. Guided by our business philosophy—"Driven by market demand, powered by technological innovation, and enabled by e-commerce"—we are committed to delivering biomedical products that are precise, high-quality, fast, and reliable. Our offerings serve pharmaceutical companies, university research institutions, hospital outpatient services, reagent providers, and distributors worldwide.

Recommended supplier

Product name Price   Suppliers Update time
$0.00/1kg
VIP1Y
Hebei Junhua Import and Export Co., LTD
2025-04-01
$0.00/25KG
VIP1Y
Shaanxi Dideu New Materials Co. Ltd
2025-02-17
$5.00/1KG
VIP2Y
Henan Fengda Chemical Co., Ltd
2024-04-10
$0.00/1kg
Nanjing Fred Technology Co., Ltd
2023-12-29
$0.00/1kg
VIP2Y
Hangzhou ICH Biofarm Co., Ltd
2023-07-03
$0.00/1KG
VIP3Y
Henan Aochuang Chemical Co.,Ltd.
2022-10-08
$300.00/1kg
Hebei Mingeng Biotechnology Co., Ltd
2022-05-05
$15.00/1KG
Zhuozhou Wenxi import and Export Co., Ltd
2021-07-10
$850.00/1Kg/Bag
Pharmahands (Taizhou) Co., Ltd.
2020-09-15
$1.00/1kg
VIP7Y
Career Henan Chemical Co
2018-12-20
INQUIRY

+86-+undefined-+86 13343427080
sales@biocarchem.com